athenahealth, Inc. (NASDAQ:ATHN) has been given an average recommendation of “Hold” by the twenty-eight ratings firms that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and thirteen have given a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $148.67.

A number of equities analysts have recently issued reports on the company. Morgan Stanley reissued an “equal weight” rating and issued a $125.00 target price (up from $108.00) on shares of athenahealth in a report on Wednesday, August 2nd. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $170.00 price target (up from $150.00) on shares of athenahealth in a report on Wednesday, August 2nd. BidaskClub cut athenahealth from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Cowen and Company cut athenahealth from an “outperform” rating to a “market perform” rating and raised their price target for the company from $127.00 to $133.00 in a report on Monday, July 31st. Finally, ValuEngine raised athenahealth from a “sell” rating to a “hold” rating in a report on Monday, July 24th.

In related news, CFO Karl Stubelis sold 3,952 shares of athenahealth stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $138.98, for a total value of $549,248.96. Following the sale, the chief financial officer now owns 21,810 shares of the company’s stock, valued at $3,031,153.80. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $140.81, for a total value of $112,648.00. The disclosure for this sale can be found here. Insiders sold a total of 14,874 shares of company stock worth $2,102,697 in the last three months. Company insiders own 3.20% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the stock. FMR LLC increased its stake in athenahealth by 0.8% in the second quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock worth $839,803,000 after buying an additional 47,341 shares in the last quarter. Janus Henderson Group PLC bought a new stake in athenahealth during the second quarter worth about $713,856,000. Morgan Stanley increased its stake in athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock worth $508,717,000 after buying an additional 397,837 shares in the last quarter. Wellington Management Group LLP increased its stake in athenahealth by 1.0% in the first quarter. Wellington Management Group LLP now owns 3,464,730 shares of the health services provider’s stock worth $390,441,000 after buying an additional 35,241 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in athenahealth by 1.8% in the second quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock worth $435,795,000 after buying an additional 53,361 shares in the last quarter.

TRADEMARK VIOLATION NOTICE: “athenahealth, Inc. (ATHN) Receives Average Rating of “Hold” from Analysts” was first published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/19/athenahealth-inc-athn-receives-average-rating-of-hold-from-analysts.html.

Shares of athenahealth (ATHN) traded up 0.30% during midday trading on Friday, hitting $141.34. The stock had a trading volume of 393,900 shares. The firm has a 50-day moving average of $142.46 and a 200 day moving average of $126.16. The firm has a market cap of $5.64 billion, a PE ratio of 179.37 and a beta of 1.77. athenahealth has a 12-month low of $90.11 and a 12-month high of $158.66.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The business had revenue of $301.10 million during the quarter, compared to analysts’ expectations of $298.68 million. During the same period in the prior year, the firm posted $0.34 EPS. athenahealth’s quarterly revenue was up 15.0% compared to the same quarter last year. On average, analysts expect that athenahealth will post $1.91 earnings per share for the current year.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.